The purpose of this study is to collect standardized data on the diagnosis and management of idiopathic (unknown cause) recurrent acute pancreatitis. The intent is to collect data for at least five years to obtain information regarding long-term outcomes and obtain comparative effectiveness data.
Study Type
OBSERVATIONAL
Enrollment
50
Aurora St. Lukes Medical Center of Aurora Health Care
Milwaukee, Wisconsin, United States
IDIOPATHIC RECURRENT ACUTE PANCREATITIS (IRAP)
Expect 750 to be treated with ERCP Expect 250 to be treated with conservative treatment. Therefore, the smaller group was used for the sample size analysis. Smallest difference in QOL for treatment is expected to be 10-20%. For smaller of two treatment groups (N=250), no effect would be 0 got better and 250 did not. If 10% of the subjects improved, 25 would get better and 225 would not. Result: Chi-square analysis yielded a highly significantly difference as follows. Chi-square= 24.253 with 1 degrees of freedom. (P = \<0.001). Yates correction for continuity was used in calculating this test.An alternate analysis is that for no effect, 125 subjects would get better and 125 patients would not (random effects model).
Time frame: The goal is to recruit 1000 subjects in 5 years.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.